3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
2
Lung Neoplasms
2
Barrett Esophagus
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Neoplasm Metastasis
1
Liver Cirrhosis
1
Hypertension, Portal
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Cysts
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Calcinosis
1
Breast Neoplasms
1
Breast Cyst
1
Arachnodactyly
1
Adenocarcinoma of Lung
1
Interventions
Paclitaxel
15
Carboplatin
9
liposomal doxorubicin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Diagnostic Imaging
×
1 year
×
Clear all
No trials found.